Production (Stage)
CareDx, Inc
CDNA
$16.95
-$0.16-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.54% | 32.04% | 23.35% | 31.26% | -6.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.54% | 32.04% | 23.35% | 31.26% | -6.75% |
| Cost of Revenue | 9.57% | 10.01% | 12.39% | 7.95% | -0.12% |
| Gross Profit | 22.02% | 46.16% | 29.66% | 44.84% | -10.10% |
| SG&A Expenses | -8.43% | 32.71% | -7.34% | -3.90% | -2.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.03% | 17.74% | -2.40% | -0.49% | -6.86% |
| Operating Income | 64.49% | 19.98% | 63.16% | 84.78% | 7.23% |
| Income Before Tax | 48.45% | 166.29% | 69.41% | 94.52% | 15.47% |
| Income Tax Expenses | 169.88% | 3.64% | 350.00% | 132.35% | -166.94% |
| Earnings from Continuing Operations | 47.94% | 166.06% | 68.46% | 94.41% | 16.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.94% | 166.06% | 68.46% | 94.41% | 16.26% |
| EBIT | 64.49% | 19.98% | 63.16% | 84.78% | 7.23% |
| EBITDA | 76.45% | 22.13% | 71.71% | 97.86% | 10.30% |
| EPS Basic | 51.31% | 164.97% | 67.70% | 94.24% | 13.10% |
| Normalized Basic EPS | 76.89% | 9.49% | 70.88% | 94.37% | 7.86% |
| EPS Diluted | 50.61% | 160.76% | 67.70% | 93.53% | 13.10% |
| Normalized Diluted EPS | 76.89% | 15.65% | 70.88% | 94.37% | 7.86% |
| Average Basic Shares Outstanding | 6.91% | 1.68% | -2.35% | -3.07% | -3.64% |
| Average Diluted Shares Outstanding | 6.91% | 9.05% | -2.35% | -3.07% | -3.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |